On 22 February 2019, the Global Fund Board approved one multi-country grant, one matching funds request and one set of interventions on the Unfunded Quality Demand (UQD) Register –– worth a total of $16.0 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). This was the 17th batch of approvals from the 2017–2019 allocations.
On 31 January 2019, the Global Fund Board approved three country grants worth $13.4 million. It also approved two multicountry grants valued at $22.5 million. The Board was acting on the recommendations of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC). See Tables 1 and 2 for listings of the country and multi-country grants.
In an investigation of Global Fund grants to Mozambique, the Office of the Inspector General (OIG) has found that the Executive Secretary of Mozambique’s Country Coordinating Mechanism (CCM) was responsible for non-compliant expenditures of $26,020 over the period of a year between 2016 and 2017, by claiming false expenses and vouchers. Of this, $22,593 was fraudulent.
On 17 August 2018 and on 26 October 2018, the Global Fund Board approved two HIV grants and three TB grants worth $28.1 million. The Board also approved $15.9 million in matching funds requests for six components.
Fluctuations monétaires : comment le Fonds mondial et les récipiendaires principaux gèrent le risque
Les fluctuations monétaires constituent une préoccupation importante pour les parties prenantes du Fonds mondial, notamment les pays bénéficiaires dont la monnaie peut connaître des variations significatives sur des périodes relativement courtes. La force du dollar US et de l’euro ces dernières années a encore aggravé le problème pour de nombreux pays.
Currency fluctuations are a major concern for Global Fund stakeholders, particularly recipient countries whose domestic currency can experience significant shifts over relatively short periods of time. The strength of both the US dollar and the Euro in recent years has further exacerbated this issue for many countries.
Mozambique’s TB/HIV funding request to the Global Fund builds on achievements of current grants, TRP says
Among the grants approved by the Board in the third batch of funding (see GFO article) were four TB/HIV grants to Mozambique. In this article, we report on the comments of the Technical Review Panel (TRP) and the Grant Approvals Committee (GAC) on the funding request from which these grants emanated.
Les cibles nationales ambitieuses de mise sous traitement ne se retrouvent souvent pas dans les cadres de résultats des subventions, selon le CAS
Ambitious national targets for getting people on treatment often not reflected in grant performance frameworks, GAC says
In its report to the Board on the third batch of grants it recommended for approval, the Grant Approvals Committee (GAC) said that it was very concerned that national programs have ambitious goals to continue scaling up antiretroviral therapy (ART), with the aim of achieving the 90-90-90 targets or even treating all patients diagnosed with HIV – but that these goals are not necessarily reflected in performance frameworks because of “limitation
Le Mozambique présente au Fonds mondial une demande de financement de 513,1 millions de dollars pour la lutte conjointe contre le VIH et la tuberculose